10x Genomics, Inc. Operating Expenses
10x Genomics, Inc. (TXG) reported Operating Expenses of $132.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-07
- 10x Genomics, Inc. operating expenses for the quarter ending 2026-06-30 was $132.05M, a 39.06% increase year-over-year.
- 10x Genomics, Inc. operating expenses for the quarter ending 2026-03-31 was $123.22M, a 14.88% decline year-over-year.
- 10x Genomics, Inc. operating expenses for the quarter ending 2025-12-31 was $132.59M, a 17.54% decline year-over-year.
- 10x Genomics, Inc. operating expenses for the quarter ending 2025-09-30 was $132.55M, a 10.37% decline year-over-year.
- 10x Genomics, Inc. operating expenses for fiscal 2025 was $504.87M, a 17.10% decline from fiscal 2024.
- 10x Genomics, Inc. operating expenses for fiscal 2024 was $609.04M, a 9.72% decline from fiscal 2023.
- 10x Genomics, Inc. operating expenses for fiscal 2023 was $674.64M, a 19.62% increase from fiscal 2022.
- 10x Genomics, Inc. operating expenses for fiscal 2022 was $563.97M, a 20.34% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $132.05M 10-Q · filed 2026-08-07 | $255.28M 10-Q · filed 2026-08-07 | $387.86M derived: sum of 3 quarters · filed 2026-08-07 | $520.41M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $123.22M 10-Q · filed 2026-05-08 | $255.81M derived: sum of 2 quarters · filed 2026-05-08 | $388.36M derived: sum of 3 quarters · filed 2026-05-08 | $483.32M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $132.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $265.13M derived: sum of 2 quarters · filed 2026-02-13 | $360.09M derived: sum of 3 quarters · filed 2026-08-07 | $504.87M 10-K · filed 2026-02-13 |
| 2025-09-30 | $132.55M 10-Q · filed 2025-11-07 | $227.51M derived: sum of 2 quarters · filed 2026-08-07 | $372.28M 10-Q · filed 2025-11-07 | $533.07M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $94.96M 10-Q · filed 2026-08-07 | $239.73M 10-Q · filed 2026-08-07 | $400.52M derived: sum of 3 quarters · filed 2026-08-07 | $548.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $144.77M 10-Q · filed 2026-05-08 | $305.57M derived: sum of 2 quarters · filed 2026-05-08 | $453.44M derived: sum of 3 quarters · filed 2026-05-08 | $599.40M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $160.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $308.67M derived: sum of 2 quarters · filed 2026-02-13 | $454.63M derived: sum of 3 quarters · filed 2026-02-13 | $609.04M 10-K · filed 2026-02-13 |
| 2024-09-30 | $147.88M 10-Q · filed 2025-11-07 | $293.83M derived: sum of 2 quarters · filed 2025-11-07 | $448.25M 10-Q · filed 2025-11-07 | $619.22M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $145.96M 10-Q · filed 2025-08-08 | $300.37M 10-Q · filed 2025-08-08 | $471.34M derived: sum of 3 quarters · filed 2026-02-13 | $661.66M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $154.41M 10-Q · filed 2025-05-09 | $325.38M derived: sum of 2 quarters · filed 2026-02-13 | $515.71M derived: sum of 3 quarters · filed 2026-02-13 | $678.68M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $170.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $361.29M derived: sum of 2 quarters · filed 2026-02-13 | $524.26M derived: sum of 3 quarters · filed 2026-02-13 | $674.64M 10-K · filed 2026-02-13 |
| 2023-09-30 | $190.32M 10-Q · filed 2024-10-29 | $353.29M derived: sum of 2 quarters · filed 2024-10-29 | $503.67M 10-Q · filed 2024-10-29 | $646.17M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $162.97M 10-Q · filed 2024-08-08 | $313.35M 10-Q · filed 2024-08-08 | $455.85M derived: sum of 3 quarters · filed 2025-02-13 | $596.54M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $150.38M 10-Q · filed 2024-04-30 | $292.88M derived: sum of 2 quarters · filed 2025-02-13 | $433.57M derived: sum of 3 quarters · filed 2025-02-13 | $583.59M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $142.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $283.19M derived: sum of 2 quarters · filed 2025-02-13 | $433.21M derived: sum of 3 quarters · filed 2025-02-13 | $563.97M 10-K · filed 2025-02-13 |
| 2022-09-30 | $140.69M 10-Q · filed 2023-11-03 | $290.71M derived: sum of 2 quarters · filed 2023-11-03 | $421.47M 10-Q · filed 2023-11-03 | $553.23M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $150.02M 10-Q · filed 2023-08-04 | $280.77M 10-Q · filed 2023-08-04 | $412.54M derived: sum of 3 quarters · filed 2024-02-15 | $529.20M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $130.75M 10-Q · filed 2023-05-04 | $262.51M derived: sum of 2 quarters · filed 2024-02-15 | $379.17M derived: sum of 3 quarters · filed 2024-02-15 | $500.43M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $131.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $248.42M derived: sum of 2 quarters · filed 2024-02-15 | $369.68M derived: sum of 3 quarters · filed 2024-02-15 | $468.65M 10-K · filed 2024-02-15 |
| 2021-09-30 | $116.66M 10-Q · filed 2022-11-03 | $237.91M derived: sum of 2 quarters · filed 2022-11-03 | $336.89M 10-Q · filed 2022-11-03 | $839.79M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $121.25M 10-Q · filed 2022-08-09 | $220.23M 10-Q · filed 2022-08-09 | $723.14M derived: sum of 3 quarters · filed 2023-02-16 | $845.80M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $98.98M 10-Q · filed 2022-05-05 | $601.88M derived: sum of 2 quarters · filed 2023-02-16 | $724.54M derived: sum of 3 quarters · filed 2023-02-16 | $796.82M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $502.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $625.57M derived: sum of 2 quarters · filed 2023-02-16 | $697.84M derived: sum of 3 quarters · filed 2023-02-16 | $774.52M 10-K · filed 2023-02-16 |
| 2020-09-30 | $122.66M 10-Q · filed 2021-11-05 | $194.93M derived: sum of 2 quarters · filed 2021-11-05 | $271.62M 10-Q · filed 2021-11-05 | $338.40M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $72.27M 10-Q · filed 2021-08-06 | $148.95M 10-Q · filed 2021-08-06 | $215.74M derived: sum of 3 quarters · filed 2022-02-18 | $270.56M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $76.68M 10-Q · filed 2021-05-07 | $143.47M derived: sum of 2 quarters · filed 2022-02-18 | $198.29M derived: sum of 3 quarters · filed 2022-02-18 | $249.47M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $66.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $121.61M derived: sum of 2 quarters · filed 2022-02-18 | $172.78M derived: sum of 3 quarters · filed 2022-02-18 | $215.43M 10-K · filed 2022-02-18 |
| 2019-09-30 | $54.82M 10-Q · filed 2020-11-12 | $106.00M derived: sum of 2 quarters · filed 2020-11-12 | $148.65M 10-Q · filed 2020-11-12 | $259.26M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $51.17M 10-Q · filed 2020-08-12 | $93.82M 10-Q · filed 2020-08-12 | $204.44M derived: sum of 3 quarters · filed 2021-02-26 | $250.74M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $42.65M 10-Q · filed 2020-05-12 | $153.27M derived: sum of 2 quarters · filed 2021-02-26 | $199.57M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-12-31 | $110.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $156.92M derived: sum of 2 quarters · filed 2021-02-26 | $228.42M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $46.30M 10-Q · filed 2019-11-12 | $117.80M 10-Q · filed 2019-11-12 | ||
| 2017-12-31 | $78.90M 10-K · filed 2020-02-27 |